View Post

U.S. Prepares for the Next Pandemic Influenza Outbreak

In COVID-19, Latest News by Precision Vaccinations

New Jersey-based Seqirus announced today that the U.S. Food and Drug Administration (FDA) granted supplemental approval of a multi-dose vial presentation of the AUDENZ™ pandemic influenza vaccine.
AUDENZ is the first-ever adjuvanted, cell-based influenza vaccine designed to help protect individuals six months of age and older against influenza A(H5N1) in the event of a pandemic.
The U.S. FDA initially approved this novel influenza vaccine in February 2020 in a single dose, prefilled syringe presentation.

View Post

Hepatitis A Unintentionally Served at Starbucks

In COVID-19, Latest News by Precision Vaccinations

In light of the case of hepatitis A in an employee at a Starbucks located in Gloucester Township, the Camden County Health Department in New Jersey confirmed on November 22, 2021, it is offering vaccines to anyone who feels they may have been exposed.
Based on the investigation and out of an abundance of caution, the Department of Health recommends any unvaccinated member of the public that patronized Starbucks at 1490 Blackwood Clementon Road on Nov. 4, 5, 6, 11, 12, or 13 to get the hepatitis A vaccine. 

View Post

Infant Vaccinations Disrupted During COVID-19 Pandemic

In COVID-19, Latest News by Precision Vaccinations

The COVID-19 pandemic has profoundly affected the lives of pregnant women and their infants, resulting in prenatal health care disruptions, stated researchers in a new study published by the JAMA Network today.
These researchers prospectively investigated how maternal experiences predicted vaccination status among infants at 3 to 5 months of age born during the early phase of the COVID-19 pandemic.
This study found ‘mothers with greater concern about perinatal infection and greater birth satisfaction had decreased risk of incomplete vaccine uptake.’